Anand Sharma

Mount Vernon Cancer Centre

Papers

1

Total Citations

1

H-Index

1

About

Anand Sharma is a urologic oncologist whose research focuses on refining treatment strategies for high-risk prostate cancer, particularly following robotic-assisted laparoscopic prostatectomy. His work addresses the clinical dilemma posed by pT3b disease—where cancer invades the seminal vesicles—and the critical role of surgical margin status in guiding postoperative management. In his notable 2022 study from a single tertiary cancer center, Sharma evaluated outcomes for patients with pT3b prostate cancer, weighing options from active surveillance to adjuvant radiotherapy and salvage therapy. While his most-cited paper has garnered 1 citation to date, his contributions lie in advancing nuanced, evidence-based decision-making for a challenging patient subset. Sharma’s research underscores the importance of individualized care in urologic oncology, helping clinicians balance oncologic control with quality of life. His work continues to inform best practices for managing high-risk prostate cancer in the robotic surgery era.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Single tertiary cancer center experience on the management of pT3b prostate cancer after robotic-assisted laparoscopic prostatectomy
1 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Mount Vernon Cancer Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago